Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 2, 2006, Pages 191-199

  Karinen, Hannele ^a   Kärkkäinen, Päivi ^a   Pihlajamäki, Jussi ^a   Janatuinen, Esko ^a   Heikkinen, Markku ^a   Julkunen, Risto ^a   Kosma, Veli Matti ^a   Naukkarinen, Anita ^a   Laakso, Markku ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Coeliac disease; Genes; HLA

Indexed keywords

GLUTEN; HEMOGLOBIN; HLA DQB1 ANTIGEN;

ADULT; ADULTHOOD; AGE; ALLELE; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; CONVALESCENCE; DIARRHEA; DISEASE SEVERITY; FAMILY; FEMALE; GENE DOSAGE; GENETIC ASSOCIATION; GLUTEN FREE DIET; HEMOGLOBIN BLOOD LEVEL; HOMOZYGOSITY; HUMAN; INTESTINE VILLUS ATROPHY; LABORATORY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SYMPTOM;

ADULT; ALLELES; BIOPSY; CELIAC DISEASE; DNA; FEMALE; GENE DOSAGE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HUMANS; MALE; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX;

EID: 32644471534     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520500206277     Document Type: Article

References (55)

1. Johnston SD, Watson RG, McMillan SA, Sloan J, Love AH. Prevalence of coeliac disease in Northern Ireland. Lancet 1997;350:1370.
2. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, et al. Celiac disease risk in the USA: high prevalence of antiendomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998;33:494-8.
3. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003;52:960-5.
4. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517-24.
5. Mäki M, Collin P. Coeliac disease. Lancet 1997;349:1755-9.
6. Farrell RJ, Kelly CP. Diagnosis of celiac sprue. Am J Gastroenterol 2001;96:3237-46.
7. Spurkland A, Sollid LM, Ronningen KS, Bosnes V, Ek J, Vartdal F, et al. Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. Hum Immunol 1990;29:157-65.
8. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-50.
9. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993;105:910-22.
10. Sollid LM. Genetics of the immune response to gluten in coeliac disease. Dig Dis Sci 1998;16:345-7.
11. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997;49:29-34.
12. Yunis JJ, Ahmed AR. Immunogenetics of dermatitis herpetiformis. Clin Dermatol 1991;9:341-6.
13. Louka AS, Sollid LM. HLA in coeliac disease: unravelling the complex genetics of a complex disorder. Tissue Antigens 2003;61:105-17.
14. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987;40:1-14.
15. Petronzelli F, Bonamico M, Ferrante P, Grillo R, Mora B, Mariani P, et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997;61:307-17.
16. Bevan S, Popat S, Braegger CP, Busch A, O'Donoghue D, Falth-Magnusson K, et al. Contribution of the MHC region to the familial risk of coeliac disease. J Med Genet 1999;36:687-90.
17. Zhong F, McCombs CC, Olson JM, Elston RC, Stevens FM, McCarthy CF, et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet 1996;14:329-33.
18. Greco L, Corazza G, Babron MC, Clot F, Fulchignoni-Lataud MC, Percopo S, et al. Genome search in celiac disease. Am J Hum Genet 1998;62:669-75.
19. King AL, Yiannakou JY, Brett PM, Curtis D, Morris MA, Dearlove AM, et al. A genome-wide family-based linkage study of coeliac disease. Ann Hum Genet 2000;64:479-90.
20. Liu J, Juo SH, Holopainen P, Terwilliger J, Tong X, Grunn A, et al. Genomewide linkage analysis of celiac disease in Finnish families. Am J Hum Genet 2002;70:51-9.
21. Neuhausen SL, Feolo M, Camp NJ, Farnham J, Book L, Zone JJ. Genome-wide linkage analysis for celiac disease in North American families. Am J Med Genet 2002;111:1-9.
22. Naluai AT, Nilsson S, Gudjonsdottir AH, Louka AS, Ascher H, Ek J, et al. Genome-wide linkage analysis of Scandinavian affected sib-pairs supports presence of susceptibility loci for celiac disease on chromosomes 5 and 11. Eur J Hum Genet 2001;9:938-44.
23. Van Belzen MJ, Meijer JW, Sandkuijl LA, Bardoel AF, Mulder CJ, Pearson PL, et al. A major non-HLA locus in celiac disease maps to chromosome 19. Gastroenterology 2003;125:1032-41.
24. Rioux JD, Karinen H, Kocher K, McMahon SG, Kärkkäinen P, Janatuinen E, et al. Genomewide search and association studies in a Finnish celiac disease population: identification of a novel locus and replication of the HLA and CTLA4 loci. Am J Med Genet 2004;130A:345-50.
25. Ploski R, Ek J, Thorsby E, Sollid LM. On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993;41:173-7.
26. Fernandez-Arquero M, Figueredo MA, Maluenda C, de la Concha FG. HLA-linked genes acting as additive susceptibility factors in celiac disease. Hum Immunol 1995;42:295-300.
27. Meddeb-Garnaoui A, Zeliszewski D, Mougenot JF, Djilali-Saiah I, Caillat-Zucman S, Dormoy A, et al. Reevaluation of the relative risk for susceptibility to celiac disease of HLA-DRB1, -DQA1, -DQB1, -DPB1, and -TAP2 alleles in a French population. Hum Immunol 1995;43:190-9.
28. Ploski R, Ascher H, Sollid LM. HLA genotypes and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol 1996;31:1092-7.
29. Arranz E, Telleria JJ, Sanz A, Martin JF, Alonso M, Calvo C, et al. HLA-DQA1*0501 and DQB1*02 homozygosity and disease susceptibility in Spanish coeliac patients. Exp Clin Immunogenet 1997;14:286-90.
30. Congia M, Cucca F, Frau F, Lampis R, Melis L, Clemente MG, et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol 1994;40:138-42.
31. Zubillaga P, Vidales MC, Zubillaga I, Ormaechea V, Garcia-Urkia N, Vitoria JC. HLA-DQA1 and HLA-DQB1 genetic markers and clinical presentation in celiac disease. J Pediatr Gastroenterol Nutr 2002;34:548-54.
32. Polvi A, Eland C, Koskimies S, Mäki M, Partanen J. HLA DQ and DP in Finnish families with celiac disease. Eur J Immunogenet 1996;23:221-34.
33. Greco L, Percopo S, Clot F, Bouguerra F, Babron MC, Eliaou JF, et al. Lack of correlation between genotype and phenotype in celiac disease. J Pediatr Gastroenterol Nutr 1998;26:286-90.
34. Bradbury P, Gordon KC. Connective tissues and stains. In: Bancroft JD, Stevens A, editors. Theory and practice of histological techniques. Edinburgh. London, Melbourne and New York: Churchill Livingstone; 1982. pp 133-4.
35. Janatuinen EK, Pikkarainen PH, Kemppainen TA, Kosma VM, Järvinen RM, Uusitupa MI, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995;333:1033-7.
36. Kemppainen TA, Kosma VM, Janatuinen EK, Julkunen RJ, Pikkarainen PH, Uusitupa MI. Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet: association with the grade of mucosal villous atrophy. Am J Clin Nutr 1998;67:482-7.
37. Roy-Choudhury D, Cooke WT, Tan DT, Banwell JG, Smits BJ. Jejunal biopsy: criteria and significance. Scand J Gastroenterol 1966;1:57-74.
38. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994;35:776-8.
39. Volta U, Molinaro N, de Franceschi L, Fratangelo D, Bianchi FB. IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys. Dig Dis Sci 1995;40:1902-5.
40. Sulkanen S, Collin P, Laurila K, Mäki M. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998;33:251-4.
41. Hallström O. Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis. Gut 1989;30:1225-32.
42. Savilahti E, Viander M, Perkkiö M, Vainio E, Kalimo K, Reunala T. IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease. Lancet 1983;1:320-2.
43. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
44. Sacchetti L, Sarrantonio C, Pastore L, Carlino V, Calcagno G, Ferrajolo A, et al. Rapid identification of HLA DQA1*0501, DQB1*0201 and DRB1*04 alleles in celiac disease by a PCR-based methodology. Clin Chem 1997;43:2204-6.
45. Clay TM, Culpan D, Pursall MC, Bradley BA, Bidwell JL. HLA-DQB1 and DQA1 matching by ambient temperature PCR-SSCP. Eur J Immunogenet 1995;22:467-78.
46. George VT, Elston RC. Testing the association between polymorphic markers and quantitative traits in pedigrees. Genet Epidemiol 1987;4:193-201.
47. Karell K, Holopainen P, Mustalahti K, Collin P, Mäki M, Partanen J. Not all HLA DR3 DQ2 haplotypes confer equal susceptibility to coeliac disease: transmission analysis in families. Scand J Gastroenterol 2002;37:56-61.
48. Brett PM, Yiannakou JY, Morris MA, Vaughan R, Curtis D, Ciclitira PJ. Common HLA alleles, rather than rare mutants, confer susceptibility to coeliac disease. Ann Hum Genet 1999;63:217-25.
49. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fausa O, et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993;178:187-96.
50. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81.
51. Partanen J. Major histocompatibility complex and coeliac disease. In: Mäki M, Collin P, Visakorpi JK, editors. Coeliac disease. Tampere: Coeliac Disease Study Group; 1997. pp 253-64.
52. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;4:713-7.
53. Van de Wal Y, Kooy Y, Van Veelen P, Pena S, Mearin L, Papadopoulos G, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585-8.
54. Holm K, Mäki M, Savilahti E, Lipsanen V, Laippala P, Koskimies S. Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet 1992;339:1500-3.
55. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 2003;100:12390-5.